Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms |
Mechanism p300-CBP transcription factors degraders(p300-CBP transcription factors degraders) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Preclinical | CN | 22 Apr 2024 | |
Acute Myeloid Leukemia | Preclinical | CN | 22 Apr 2024 |